Education, Science, Technology, Innovation and Life
Open Access
Sign In

Modulation of MAPK Signaling Pathway by Traditional Chinese Medicine for the Treatment of Diabetic Renal Fibrosis

Download as PDF

DOI: 10.23977/medcm.2023.050806 | Downloads: 27 | Views: 405

Author(s)

Hongru Liu 1, Nan Guo 1, Chenxi Li 1, Ping Fan 2

Affiliation(s)

1 Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, 712046, China
2 Shaanxi Provincial Hospital of Chinese Medicine, Xi'an, Shaanxi, 710003, China

Corresponding Author

Ping Fan

ABSTRACT

Diabetic nephropathy (DN) is one of the complications of diabetes mellitus, which has become an economic burden for human societies all over the world, and its progression may lead to renal fibrosis in later stages, altering the prognosis and quality of survival of diabetic patients. Numerous studies have shown that inflammation, oxidative stress, and endoplasmic reticulum stress promote the progression of renal fibrosis in diabetic nephropathy. Subject to the limitations of conventional Western medical treatment strategies, Chinese medicine has unique advantages in intervening diabetic renal fibrosis, and research on Chinese medicine monomers and compound formulas has made some progress so far, confirming that a variety of signaling pathways can delay the development of diabetic nephropathy and renal fibrosis, among which, the MAPK signaling pathway promotes inflammatory and fibrotic responses, and regulates the level of glucose and lipid metabolism. Experimental studies have shown that the treatment of DN by TCM may be realized through the MAPK signaling pathway. The article reviewed the regulatory mechanism of MAPK signaling pathway on DN and the progress of TCM monomers and TCM combinations in regulating the MAPK signaling pathway for the treatment of DN, with the aim of providing more theoretical basis for the research and development of TCM for the treatment of DN, and for the clinical use of medication. 

KEYWORDS

Traditional Chinese medicine; renal fibrosis; diabetic nephropathy; signaling pathway; mitogen-activated protein kinase (MAPK)

CITE THIS PAPER

Hongru Liu, Nan Guo, Chenxi Li, Ping Fan, Modulation of MAPK Signaling Pathway by Traditional Chinese Medicine for the Treatment of Diabetic Renal Fibrosis. MEDS Chinese Medicine (2023) Vol. 5: 40-47. DOI: http://dx.doi.org/10.23977/medcm.2023.050806.

REFERENCES

[1] Van Buren P N, Toto R. Current update in the management of diabetic nephropathy [J].Curr Diabetes Rev, 2013, 9(1):62-77.
[2] Zhang Zhirong, Han Weixia, Wang Chen. New progress on the molecular mechanism of diabetic nephropathy [J]. Chinese Electronic Journal of Nephrology, 2021, 10(2): 90.
[3] Endocrinology and Metabolic Diseases Professional Committee of Integrated Traditional Chinese and Western Medicine Physicians Branch of Chinese Medical Doctor Association, Yu Jiangyi, Ni Qing, Liu Su. Clinical Guidelines for the Prevention and Treatment of Diabetic Kidney Disease in China [J]. Journal of Traditional Chinese Medicine, 2022, 63(2):190-197.
[4] Gao Yanbin, Liu Tonghua, Nan Zheng, et al. Chinese medicine diagnosis and treatment standard of diabetic kidney disease [J]. World Journal of Integrative Medicine, 2011, 6(6): 548.
[5] Sun H, Saeedi P, Karuranga S et al. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045[J]. Diabetes Research and Clinical Practice, 2022, 183:109119.
[6] Liang Yajing, Yang Wanxi. Kinesins in the MAPK cascade: how kinesin motors are involved in the MAPK pathway? [J]. Gene, 2019(5):684:1-9.
[7] Li Zhenzhen, Liu Xianghua, Wang Baoying, et al. Pirfenidone suppresses MAPK signalling pathway to reverse epithelial-mesenchymal transition and renal fibrosis [J]. Nephrology (Carlton) 2017, 22(8):589-597.
[8] Fang Xun, Hu Jun, Zhou Hongyan. Knock-Down of Long Non-Coding RNA ANRIL Suppresses Mouse Mesangial Cell Proliferation, Fibrosis, Inflammation via Regulating Wnt/β-Catenin and MEK/ERK Pathways in Diabetic Nephropathy [J]. Experimental and clinical endocrinology & diabetes: official journal, German Society of Endocrinology [and] German Diabetes Association, 2020, 130(1).
[9] Sun Wen. Experimental study on the renoprotective effect of total saponins of Panax ginseng on the kidney of rats with diabetic nephropathy and its effect on TGF-β1/p38MAPK signaling pathway[D]. Beijing University of Traditional Chinese Medicine, 2010.
[10] Gao Zihan, Li Ruifang, Lu Xingzhi, et al. Effects of yam polysaccharide on renal function and aldose reductase pathway in mice with diabetic nephropathy [J]. Chinese herbal medicine, 2019, 42(3):643-646.
[11] Dong Zhonghua, Sun Yueyue, Wei Guangwei, et al. A Nucleoside/Nucleobase-Rich Extract fromCordyceps Sinensis Inhibits the Epithelial-Mesenchymal Transition and Protectsagainst Renal Fibrosis in Diabetic Nephropathy [J]. Molecules, 2019, 24(22): 4119.
[12] Chen Hongjin, Yang Xi, Lu Kongqin, et al. Inhibition of high glucose-induced inflammation andfibrosis by a novel curcumin derivative prevents renal and heart injury in diabeticmice [J]. Toxicology letters, 2017, 278:48-58.
[13] Ren Dongwen. Study on the effect of ginsenoside Compound K in the treatment of diabetic kidney disease and its mechanism [D]. Tianjin University of Traditional Chinese Medicine, 2022.
[14] Zhu Yuanmei. Study on the ameliorative effect and mechanism of salvinorin B on diabetic renal fibrosis [D]. Anhui South Medical College, 2019.
[15] He Riming, Men Ling, Yi Wuyong, Yi Tigang, Li Shunmin, Yang Shudong. Effect of baicalein on p38MAPK expression in renal tissues of rats with diabetic nephropathy [J]. Guangdong Medicine, 2016, 37(20):3006-3009.
[16] Mao Zhimin, Wan Yigang, Sun Wei, Chen Haoli, Huang Yanru, Shi Ximiao, Yao Jian. Role and mechanism of inhibition of oxidative stress and p38MAPK signaling pathway activity in renal tissues of diabetic nephropathy to improve renal fibrosis by Huang Kui capsule [J]. Chinese Journal of Traditional Chinese Medicine, 2014, 39(21):4110-4117.
[17] Gu Liyuan, Sun Yun, Tang Haitao, Xu Zhengxin, et al. Huangkui capsulei 1 combination with metformin amelforates diabetic nephropathy via the KIotho/TGF-B 1/p38MAPK sign aling pathwaylul [J]. Ethnopharmacol, 2021, 281:113548.
[18] Tong Pan, Huang Xuekuan, Shen Qing, et al. Effects of Fukui Kung Fang on p38 MAPK signaling pathway in rats with chronic renal failure [J]. Chinese Journal of Experimental Formulas, 2020, 26(14):105-110.
[19] Tong Yu, Gao Yanbin, Wang Xiaolei, Tian Nianxiu, Geng Jianguo. Tongxinluo regulates p38 MAPK pathway to inhibit extracellular matrix deposition [J]. Global Chinese Medicine, 2017, 10(02):146-150.
[20] Wugedunqiqige, Zhao Zongjiang, Jiang Yufeng, Yang Meijuan, Zhang Xinxue, Zhang Xiaomei, Du Lei. Protectory effects of Tang Shen Ping Capsule on kidneys in STZ-induced diabetic nephropathy rats and TGF-β_1/p38MAPK signal pathway [J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2012, 27(04):1092-1097+1220-1221.
[21] Qin Wenmin, Zhou Caihong, Yang Kerang. Effects of Danhong Huayu oral solution on rats with diabetic nephropathy [J]. Journal of Chinese Medicinal Materials, 2016, 39(09):2114-2117.
[22] Yu Xiang. The effect of Tongfang Drainage Formula on renal fibrosis and TGF-β1/p38MAPK pathway in rats with chronic kidney disease [D]. Nanjing University of Traditional Chinese Medicine, 2019.
[23] Gao Xue, Liu Hongfang, An Zhichao, He Qiying. QiDiTangShen Granules Reduced Diabetic Kidney Injury by Regulating the Phosphorylation Balance of the Tyrosine and Serine Residues of Insulin Receptor Substrate 1 [J]. Evidence-based Complementary and Alternative Medicine, 2018:1-12.
[24] Zeng Wenying, Xin Chuanwei, Yu Xiali, Xia Zhongni. Effects of thirst-quenching combination on the expression of P38MAPK-FN in renal tissues of db/db mice [J]. China Traditional Chinese Medicine Science and Technology, 2020, 27(02):183-185.

Downloads: 4245
Visits: 168410

Sponsors, Associates, and Links


All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.